Emerging immunologic biomarkers: Setting the (TNM-Immune) stage

Clinical Cancer Research

Volumn 20, Issue 8, 2014, Pages 2023-2025

  Taube, Janis M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; CELLULAR DISTRIBUTION; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; TERTIARY LYMPHOID TISSUE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ESCAPE; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT; ANIMAL; COLORECTAL TUMOR; FEMALE; IMMUNOLOGY; MALE; T LYMPHOCYTE;

ANIMALS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOID TISSUE; MALE; T-LYMPHOCYTES;

EID: 84898948823     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-0328     Document Type: Article

References (12)

1. Di Caro G, Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A, et al. Occurrence of tertiary lymphoid tissue is associated to T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin Cancer Res 2014;20:2147-58.
2. Galon J, Mlecnik B, Bimndea G, Angell HK, Berger A, Lagorce C, et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumors. J Pathol 2014;232:199-209.
3. Bindea G, Mlecnik B, Fridman W, Pages F, Galon J. Natural immunity to cancer in humans. Curr Opin Immunol 2010;22:215-22.
4. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumors: impact on clinical outcome. Nat Rev Cancer 2012;12:298-306.
5. Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 2011;29:610-8.
6. Dieu-Nosjean MC, Antione M, Danel C, Heudes D, Wislez M, Poulot V, et al. Long term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008;26:4410-7.
7. Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 2011;71:6391-9.
8. Taube JM, Anders RA, Young GD, Xu H, Sharma R, McMiller TL, et al. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 2012;4:127ra37.
9. Ascierto PA, Capone M, Urba WJ, Bifulco CB, Botti G, Lugli A, et al. The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment. J Transl Med 2013;11:1-4.
10. Gajewski TF, Schreiber H, Fu Y. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013;14:1014-22.
11. Zheng L, Edil B, Nguyen T, Yager A, Bever K, Sharma R, et al. Novel tertiary lymphoid aggregates induced in pancreatic adenocarcinoma by an allogenic GM-CSF secreting pancreatic tumor vaccine as a neoadjuvant treatment. 2010 ASCO Gastrointestinal Cancer Symposium. Orlando, FL. Jan 22-24, 2010. Abstract #157.
12. Thomas NE, Busam KJ, From L, Kricker A, Armstrong BK, Anton- Culver H, et al. Tumor-infiltrating lymphocyte grade in Primary Melanomas is independently associated with melanoma-specific survival in the population-based genes, environment, and melanoma study. J Clin Oncol 2013;31:4252-9.